Choice A rationale:

Fulminant hepatitis is a severe and life-threatening complication of hepatitis E, particularly in pregnant women. It can lead to liver failure, and timely monitoring is crucial to detect any early signs of deterioration in the patient's condition. Pregnant women with hepatitis E require close observation and frequent assessment of liver function to ensure prompt intervention if needed.

Choice B rationale:

Administering hepatitis B immunoglobulin (HBIG) to exposed contacts is not the priority in managing a patient with hepatitis

E. Hepatitis E is caused by a different virus (hepatitis E virus) and is not effectively prevented by hepatitis B immunoglobulin.

Choice C rationale:

Educating the patient about the benefits of hepatitis C vaccine is not relevant to the care of a patient with hepatitis

E. These are two different types of viral hepatitis, caused by distinct viruses (hepatitis C virus and hepatitis E virus), and each requires specific management.

Choice D rationale:

Advising the patient to avoid sexual contact until cleared of infection is important in some cases, but it is not the priority intervention for a patient with hepatitis

E. The primary concern in hepatitis E is monitoring for complications, especially in pregnant women, as discussed in choice A rationale.